Revanesse is a brand of injectable hyaluronic acid-based fillers developed by Prollenium. These cosmetic fillers assist in reversing and lessening the signs of aging that can appear, such as moderate to severe wrinkles, loss of elasticity and sallowness. Made in Canada, these fillers are made from a patented wet milling technology that results in more spherical, uniform hyaluronic acid particles, giving these products greater durability, moldability, and consistency than that of other dermal filler brands.
The Revanesse collection consists of several products customized to handle all types of aging-related facial skin concerns: Pure, which revitalizes and rehydrates the face; Revanesse, a viscosity filler suitable for the treatment of fine lines and wrinkles; Ultra, a high-viscosity filler that helps treat medium to deep wrinkles and folds; and Lips, for lip augmentation and definition.
Revanesse products are ideally used in men and women above the age of 18 who are looking to control concerns related to facial aging, such as dehydration, wrinkles and lines, and sunken facial areas. This brand of injectables is also suitable for use in patients who want to alter or enhance their facial features in a minimally invasive manner.
Candidates should not have a history of hypersensitivity to hyaluronic acid or its derivatives, and should not have any inflammatory skin diseases, such as acne, in the area to be treated. These products are also contraindicated in patients that are prone to scarring.
Revanesse injectables are primarily made of hyaluronic acid, a naturally occurring substance in the body. In aging skin, the amount of hyaluronic acid found within the skin is markedly less than that found in younger skin, and this loss is what causes skin to sag and become dehydrated. Like other hyaluronic acid dermal fillers, Revanesse acts to replenish the skin with hyaluronic acid, filling out lines and leaving skin moisturized and supple.
The hyaluronic acid in Revanesse is cross-linked through patented Thixofix® technology, which allows the gel to withstand great amounts of pressure with minimal break down of the injected hyaluronic acid. This preserves the native structure of the hyaluronic acid particles when delivered to the treated area, ensuring long-lasting effects.
The ReDexis fillers have the added ingredient of Dextranomer Beads, a derivative of glucose. When injected into the skin, these attract and bind to glycosaminoglycans (GAGs) and elastin forming a new scaffold of collagen at the site of injection. This way, ReDexis allows for the regeneration of collagen at the treatment site for longer-lasting and more natural looking results.
Treatment with Revanesse should only be performed by a licensed and trained medical practitioner. The procedure itself is very simple and quick (a treatment session usually lasts 15 minutes to an hour).
Before treatment, inform your patient that they should discontinue use of anti-inflammatory drugs (e.g. aspirin) 3 days prior to treatment to prevent excessive bleeding or swelling at the injection site. Immediately before treatment, ensure that skin is cleansed and free of makeup or other cosmetics.
To administer the injection, first disinfect the areas of skin that are to be treated with an appropriate disinfectant. If applicable, administer an injection of local anesthetic to the treatment site before proceeding with the Revanesse injection. Refer to the product leaflet for the relevant use instructions.
With its patented method of stabilizing hyaluronic acid particles, Revanesse results last longer than those of its competitors. Depending on the product used, as well as treatment area, patients can expect a Revanesse treatment to last an average of 6 months. Some of these fillers can last up to 18 months or longer.
Revanesse products are made of non-animal hyaluronic acid and carries with it a minimal risk of any allergic reactions. These products have been extensively tested in clinical trials with proven results that assure its safety in use.
As with all other dermal filler procedures involving injections, a treatment with Revanesse carries the possibility of bruising, swelling, and redness at the injection site. These effects should dissipate within a week. Patients should seek medical attention if these symptoms persist, or if other symptoms arise after the procedure.
Patients can enjoy the benefit of minimal recovery time. In almost all cases they will be able to resume their daily activities immediately following treatment. As with all procedures of this type, some swelling and bruising will occur; these symptoms can be alleviated by using the appropriate aftercare methods. In order to ensure optimal treatment outcome, patients should avoid extreme heat exposure such as saunas or sunbathing for 2 weeks after treatment, and to refrain from excessive facial movements or massaging the treated areas.
Patients typically pay about £180 to £225 per syringe for Revanesse treatment in Europe. This range is dependent on the geographical location (USA, UK, Autralia, Canada, etc), practitioner and treatment type.